GAVINI, Elisabetta
 Distribuzione geografica
Continente #
NA - Nord America 15.880
AS - Asia 8.503
SA - Sud America 4.948
EU - Europa 4.872
AF - Africa 274
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 12
Totale 34.519
Nazione #
US - Stati Uniti d'America 15.550
BR - Brasile 4.402
SG - Singapore 3.285
CN - Cina 2.518
UA - Ucraina 1.634
HK - Hong Kong 802
VN - Vietnam 694
IT - Italia 684
DE - Germania 670
FR - Francia 457
SE - Svezia 371
FI - Finlandia 319
GB - Regno Unito 205
AR - Argentina 196
TR - Turchia 181
IN - India 176
BD - Bangladesh 134
CA - Canada 119
MX - Messico 110
IQ - Iraq 101
RU - Federazione Russa 94
EC - Ecuador 93
VE - Venezuela 78
UZ - Uzbekistan 77
ZA - Sudafrica 76
PK - Pakistan 75
KR - Corea 70
CZ - Repubblica Ceca 60
JP - Giappone 59
MA - Marocco 56
PL - Polonia 55
CO - Colombia 45
ES - Italia 42
BE - Belgio 39
EE - Estonia 38
ID - Indonesia 38
PY - Paraguay 38
PE - Perù 36
AT - Austria 34
JO - Giordania 31
TN - Tunisia 31
CL - Cile 29
KE - Kenya 29
NL - Olanda 28
AU - Australia 26
AZ - Azerbaigian 24
DZ - Algeria 24
SA - Arabia Saudita 24
AE - Emirati Arabi Uniti 23
EG - Egitto 23
NP - Nepal 21
DO - Repubblica Dominicana 20
HN - Honduras 20
UY - Uruguay 18
AL - Albania 17
LT - Lituania 17
IR - Iran 16
JM - Giamaica 16
KZ - Kazakistan 16
PH - Filippine 15
OM - Oman 14
PA - Panama 13
RO - Romania 13
BG - Bulgaria 12
IL - Israele 12
BO - Bolivia 10
BY - Bielorussia 10
RS - Serbia 10
AM - Armenia 9
BN - Brunei Darussalam 9
IE - Irlanda 9
LB - Libano 9
MY - Malesia 9
NI - Nicaragua 9
AO - Angola 8
BH - Bahrain 8
SN - Senegal 8
CR - Costa Rica 7
GR - Grecia 7
KG - Kirghizistan 7
CH - Svizzera 6
EU - Europa 6
GE - Georgia 6
MN - Mongolia 6
PS - Palestinian Territory 6
CI - Costa d'Avorio 5
DK - Danimarca 5
GT - Guatemala 5
HU - Ungheria 5
QA - Qatar 5
SY - Repubblica araba siriana 5
TH - Thailandia 5
ET - Etiopia 4
HR - Croazia 4
KW - Kuwait 4
LV - Lettonia 4
MD - Moldavia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
GA - Gabon 3
Totale 34.466
Città #
Dallas 6.387
Singapore 1.705
Chandler 1.476
San Jose 1.171
Jacksonville 942
Hong Kong 783
Ashburn 631
Princeton 532
Beijing 503
New York 441
Nanjing 403
São Paulo 343
Lauterbourg 275
Ho Chi Minh City 238
Sassari 231
Dearborn 223
Wilmington 211
Boardman 172
Los Angeles 165
Shanghai 160
Hanoi 155
Santa Clara 149
Nanchang 148
Belo Horizonte 127
Rio de Janeiro 126
Ann Arbor 124
Tianjin 116
Shenyang 105
Hebei 93
Changsha 87
Council Bluffs 76
Brasília 74
Woodbridge 74
Curitiba 69
Helsinki 69
Tashkent 69
Porto Alegre 66
Seoul 65
Jiaxing 60
Orem 60
Jinan 58
Munich 58
Tokyo 57
Baghdad 55
Chennai 55
Salvador 55
Izmir 51
The Dalles 51
Andover 50
Columbus 50
San Francisco 49
Mountain View 47
Brno 46
Norwalk 44
Campinas 43
Kunming 43
Chicago 41
Buffalo 40
Warsaw 40
Brussels 39
Hangzhou 39
Haiphong 37
Toronto 37
Istanbul 36
Johannesburg 36
Ningbo 36
Buenos Aires 35
Da Nang 35
Denver 35
Romola 35
Guayaquil 34
Guarulhos 33
Frankfurt am Main 32
Stockholm 32
Fortaleza 31
Juiz de Fora 31
Brooklyn 30
Goiânia 30
Montreal 30
Quito 29
Santo André 29
Atlanta 27
London 27
Mexico City 27
Perugia 27
Dhaka 26
Osasco 26
Ribeirão Preto 26
Amman 25
Houston 25
Taizhou 25
Zhengzhou 25
Cagliari 23
Guangzhou 23
Lima 23
Recife 23
Volta Redonda 23
Baku 22
Canoas 22
Lahore 22
Totale 21.045
Nome #
Hyaluronic acid: Development and application in drug delivery systems. 301
Activity in vitro of Meropenem against clinical isolates 267
Nasal Administration of Hyaluronic Acid-Based Hybrid Nanoparticles Loaded with Dimethyl Fumarate. 253
Hyaluronic acid based-hybrid nanoparticles for targeted nose-to-brain delivery of dimethyl fumarate. 229
Aqueous injection of quercetin: an approach for confirmation of its direct in vivo cardiovascular effects 229
Benzotriazole: an overview on its versatile biological behaviour 228
Antibacterial activity of Na-clinoptilolite against Helicobacter pylori: in-vitro tests, synergistic effect with amoxicillin and stability of the antibiotic formulated with the zeolite 219
A new diffusion system for the evaluation of transmucosal permeation across synthetic or biological membranes 218
Hybrid Nanoparticles for Intranasal delivery of Dimethyl Fumarate. 213
A new sensitive reversed phase high-performance liquid chromatography method for the quantitative determination of metoclopramide in canine plasma 213
Lemon-derived exosomes as drug delivery systems 212
A pharmacokinetic study on thymol-β-cyclodextrin complex. 211
Media milling optimization for rapid extraction of nanovesicles from lemon 207
Lemon derived exosome-like nanovesicles as drug delivery system 206
Hyaluronic acid-based hybrid nanoparticles for intranasal delivery of dimethyl fumarate 206
Rutin-loaded nasal hybrid nanoparticles: assessing potential protection from anthracycline-induced brain endothelial damage. 205
Impact of hyaluronic acid molecular weight on silibinin intranasal delivery via hybrid nanoparticle formulation 204
Silibinin-loaded amphiphilic nanoparticles: A promising drug delivery system for lung cancer therapy. 203
A new sensitive reversed phase HPLC method for the quantitative determination of metoclopramide in canine plasma 203
MEDIA MILLING: A PROMISING METHOD FOR RAPID EXTRACTION OF LEMON-DERIVED NANOVESICLES 202
Antagonistic activities of natural zeolite against Helicobacter pylori infection 201
Can clinoptilolite help fight Helicobacter pylori? Results of in-vitro tests 198
Clinical Assessment of New Topical Cream Containing Two Essential Oils Combined with Tretinoin in the Treatment of Acne 188
Green Routes for Bio-Fabrication in Biomedical and Pharmaceutical Applications 187
In vitro antibacterial activity of antiseptics against vaginal lactobacilli 186
Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives 185
La silibinina incapsulata in nanoparticelle mostra aumentata citotossicità rispetto alla molecola libera in cellule di carcinoma polmonare. 184
Antibacterial activity of Zn-loaded Cuban zeolite against Helicobacter pylori in comparison to its Na-loaded and unmodified counterparts 181
Alginate polymeric film containing propolis: characterisation and in vitro permeation behaviour 181
Natural collagenic skeleton of marine sponges in pharmaceutics: Innovative biomaterial for topical drug delivery 180
Silibinin-loaded amphiphilic nanoparticles as an efficient drug delivery system for lung cancer therapy. 179
Celle di permeazione 179
Gastrointestinal controlled release of Rose Bengal from its Chitosan Salt embedded in alginate matrix. 177
Clobetasol-17-propionate loaded microemulsions as innovative drug delivery systems targeted to topical inflammatory diseases 177
Analysis of Accelerated In Vitro Release Profiles For PLA Microspheres Loaded with an LHRH Antagonist Decapeptide 175
Evaluation of alginate compressed matrices as prolonged drug delivery systems 175
Encapsulation and modified-release of thymol from oral microparticles as adjuvant or substitute to current medications 174
Artichoke extract as penetration enhancer in topical gel formulation: in-vitro and in-vivo studies 173
Development of solid nanoparticles based on Hydroxypropyl-beta-cyclodextrin aimed for the colonic transmucosal delivery of Diclofenac sodium 173
Administration of drug loaded chitosan microparticles and brain uptake 172
Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of Ketoprofen 172
Controlled release hydrogel produced by frontal polymerization for veterinary use 169
In situ synchrotron radiation investigation of V2O5–Nb2O5 metastable compounds: transformational kinetics at high temperatures with a new structural solution for the orthorhombic V4Nb20O60 phase 167
Determinazione simultanea dei componenti caratteristici di Crocus sativus L 164
Intranasal delivery of genistein-loaded nanoparticles as a potential preventive system against neurodegenerative disorders 162
Bioactive dosage forms for the healing of skin and mucosa lesions: development of lipidic microplatforms (LM) based on propolis 161
Alginate and chitosan microspheres containing metoclopramide and intended for nasal administration 160
Natural zeolites for pharmaceutical formulations: Preparation and evaluation of a clinoptilolite-based material 159
Spray-dried PDLLA microspheres containing Carboplatin for veterinary use: in vitro and in vivo studies 159
Carboplatin Sustained Delivery System Using Injectable Microspheres 156
Investigation of Cytotoxicity and Cell Uptake of Cationic Beta-Cyclodextrins as Valid Tools in Nasal Delivery 156
A water-soluble preparation for intravenous administration of isorhamnetin and its pharmacokinetics in rats 155
Biodegradable microspheres as intravitreal delivery systems for the prolonged drug release. What is their actually in the nanoparticle era? 155
Transmucosal Solid Lipid Nanoparticles to Improve Genistein Absorption Via Intestinal Lymphatic Transport 154
Antibacterial activity of meropenem and post-antibiotic effect on selected bacteria 154
Nanotechnology-based rose Bengal: A broad-spectrum biomedical tool 153
Bio-based topical system for enhanced salicylic acid delivery: preparation and performance of gels 153
Bilayer-tablets based on poly (ε−caprolactone) and polymethylmethacrilates as controlled release systems for ruminants, 151
Synthesis of 2-(Quinoxalin-2-ylamino-benzotriazolyl) Pentanedioic Derivatives as Potential Anti-Folate Agents 151
Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug loaded chitosan microspheres 148
Development of natural zeolite-based systems as drug carriers to be used against gastric infections caused by Helicobacter pylori 148
Solid Lipid Nanoparticles as Formulative Strategy to Increase Oral Permeation of a Molecule Active in Multidrug-Resistant Tuberculosis Management 146
Preparation and In Vivo Toxicity Study of Solid Lipid Microparticles as Carrier for Pulmonary Administration 146
ALGINATE AND CHITOSAN MICROSPHERES FOR NASAL ADMINISTRATION OF CARBAMAZEPINE 145
Pyridazine N-Oxides. III. Synthesis and “in vitro” antimicrobial properties of N-Oxide derivatives based on tricyclic indeno[2,1-c]pyridazine and benzo [f]cinnoline systems 144
Chitosan microspheres as carrier of an antiamoebic drug: Rokitamycin 144
CONTROLLO DELLE CARATTERISTICHE TECHNOLOGICHE E DELLA DISSOLUZIONE 'IN VITRO' DI DICLOFENAC DA COMPRESSE A RILASCIO MODIFICATO 140
Biodegradabile controlled release tablets 140
Prolonged skin retention of clobetasol propionate by bio-based microemulsions: a potential tool for scalp psoriasis treatment 140
Alginate mucoadhesive microspheres as nasal controlled release systems for brain targeting of dopamine 140
Pyridazine N-oxides. I. Synthesis and in vitro antimicrobial evaluation of 3-methyl-4-aryl-6-R-pyridazine N-oxides 139
DEVELOPMENT OF SULPHUR-SALICYLIC GEL SYSTEMS AS NEW BIOACTIVE FORMULATIONS FOR THE TOPICAL TREATMENT OF ACNE VULGARIS 139
A thermosensitive chitosan hydrogel: An attempt for the nasal delivery of dimethyl fumarate 139
Hydroxypropyl-β-cyclodextrin formulated in nasal chitosan microspheres as candidate therapeutic agent in Alzheimer's disease 137
Evaluation of Manuka honey as an adjuvant antimicrobial preservative in a O/W emulsion 136
Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer's therapy 136
Deferoxamine Mesilate For The Treatment Of Stroke: A Formulative Study On Nasal Microspheres 136
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries 135
EXPLOITING CLINOPTILOLITE AGAINST HELICOBACTER PYLORI: POSSIBILITY OR UTOPIA? 135
Increasing protective activity of genistein by loading into transfersomes: A new potential adjuvant in the oxidative stress-related neurodegenerative diseases? 134
Design and evaluation of dry-coated tablets for colonic delivery of diclofenac sodium 133
Development of nasal formulations for a hydrophilic iron chelator, deferoxamine, useful in neurodegenerative disorders 132
Composite chitosan/alginate hydrogel for controlled release of deferoxamine: a system to potentially treat iron dysregulation diseases 132
Marine sponges (Porifera, Dictyoceratida) as promising biomaterial for the development of a novel wound dressing 131
Indocyanine Green Loaded Polymeric Nanoparticles: Physicochemical Characterization and Interaction Studies with Caco-2 Cell Line by Light and Transmission Electron Microscopy 130
Mucoadhesive microspheres for nasal administration of Cyclodextrins 129
Spray-dried microspheres containing ketoprofen formulated into capsules and tablets 129
Propolis as lipid bioactive nano-carrier for topical nasal drug delivery 128
In situ forming poly(ε-caprolactone) microspheres for transarterial embolization therapy 128
Improving in vivo oral bioavailability of a poorly soluble drug: a case study on polymeric versus lipid nanoparticles 127
Solid microparticles based on chitosan or methyl-β-cyclodextrin: A first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate 125
Frontal polymerization as a new method for developing drug controlled release systems (DCRS) based on polyacrylamide 123
In-vitro evaluation of alginate compressed matrices as sustained drug delivery systems. 123
In situ forming biodegradable poly(ε-caprolactone) microsphere systems: a challenge for transarterial embolization therapy. In vitro and preliminary ex vivo studies 123
Pyridazine N-oxides. II. Synthesis and in vitro antimicrobial evaluation of 3-chloro-4-carbamoyl-5-aryl-6-methyl-pyridazine N-oxides 123
Solid lipid nanoparticles: an interesting approach for oral delivery of Genistein 123
Sintesi e attività microbiologica in vitro di 3-cloro-4-carbamoil-5-aril-6-metil-piridazine N-ossidi 123
Lymph node metastases: importance of detection and treatment strategies 123
Identification and Determination of GnRH antagonist Gelling at Injection Site 122
Biodegradable controlled release tablets,– 122
Totale 16.541
Categoria #
all - tutte 129.972
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.972


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 0 0 0 0 0 0 0 39
2021/20221.293 198 4 3 13 21 16 63 104 98 65 172 536
2022/20232.829 311 144 64 466 312 464 2 323 487 15 130 111
2023/20241.111 144 70 26 23 168 304 45 46 2 23 81 179
2024/20258.771 87 66 487 175 342 285 694 1.758 3.026 1.275 334 242
2025/202614.747 571 2.844 4.358 1.832 1.035 723 1.692 333 522 500 282 55
Totale 34.887